前白血病单细胞景观揭示了突变特异性机制和基因程序,可以预测AML患者的结果
Tomoya Isobe1, Iwo Kucinski1, Melania Barile1
1Wellcome-MRC Cambridge Stem Cell Institute, Department of Hematology, University of Cambridge, Cambridge, UK.
Cell genomics
|December 20, 2023
概括
单细胞RNA测序揭示了突变如何影响急性髓性白血病 (AML) 发展中的细胞行为. 这项研究确定了关键的转录性变化,并开发了一个评分系统来预测患者的结果.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 基因组学就是基因组学.
背景情况:
- 急性骨髓性白血病 (AML) 和骨髓性瘤是由体突变引起的,这些突变为造血干细胞和祖细胞提供了健康优势.
- 目前对突变效应的理解受到大量细胞群体分析的限制,这阻碍了对细胞异质性的详细见解.
研究的目的:
- 解读异质细胞适应性,以应对白血病前的突变性扰乱.
- 在单细胞分辨率下,以突变驱动的细胞丰度变化,血统命运,新陈代谢和基因表达的特征.
主要方法:
- 单细胞RNA测序在八种不同的小鼠模型上进行,这些小鼠模型是骨髓性恶性瘤.
- 生成了269,048个单细胞概况来分析白血病前的突变效应.
主要成果:
- 在细胞丰富度,血统命运,新陈代谢和基因表达中推断的突变驱动的扰乱.
- 鉴定了与差异化偏差相关的转录性改变的细胞群.
- 开发了一种11基因评分系统 (Stem11),根据白血病前的转录特征预测AML患者的结果.
结论:
- 单细胞分辨率预白血病生物学的深度表征增强了对AML异质性的理解.
- 这些发现可以为急性髓性白血病患者提供更有效的风险分层策略.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...


